Therapeutic Action
Angiotensin converting enzyme inhibitor (ACE)
PDF page 129
Drug reference
Angiotensin converting enzyme inhibitor (ACE)
PDF page 129
Hypertension Chronic heart failure
PDF page 129
Do not administer to patients with history of enalapril-related angioedema. May cause: hypotension, dizziness, headache, gastrointestinal disturbances, dry cough, renal impairment, hyperkalaemia, hyponatraemia; allergic reactions, angioedema; hypoglycaemia, haematological disorders. Avoid or monitor combination with: potassium-sparing diuretics and/or potassium chloride (risk of hyperkalaemia); non steroidal anti-inflammatory drugs and/or diuretics (risk of renal impairment). Monitor combination with: other antihypertensive drugs (risk of hypotension); drugs that provoke hypotension (e.g. haloperidol, amitriptyline); oral antidiabetics and insulin (risk of hypoglycaemia). Pregnancy: CONTRA-INDICATED Breast-feeding: no contra-indication at recommended doses
PDF pages 129, 130
5 mg and 20 mg tablets
PDF page 129
Hypertension Adult: start with 5 mg once daily, then increase the dose gradually every 1 to 2 weeks, according to blood pressure, up to 10 to 20 mg once daily (max. 40 mg daily) In elderly patients, patients taking a diuretic or patients with renal impairment: start with 2.5 mg once daily then adapt dose according to renal function. Chronic heart failure Adult: Week 1: 2.5 mg once daily for 3 days then 5 mg once daily Week 2: 10 mg once daily for 3 days then 20 mg once daily The usual dose is 10 to 20 mg once daily or 5 to 10 mg 2 times daily depending on tolerance (max. 40 mg daily). Reduce dosage in patients with renal impairment.
PDF page 129
According to clinical response
PDF page 129
– Below 25 °C
PDF page 130
start with 2.5 mg once daily then adapt dose according to renal function.
PDF page 129